Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cadre Holdings, Inc. (NYSE: CDRE) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a Delaware corporation listed on the New York Stock Exchange under the symbol CDRE, Cadre submits current reports on Form 8‑K, annual and quarterly reports, and other documents that describe its operations in safety and survivability equipment for law enforcement, first responder, military and nuclear markets.
In its Form 8‑K filings, Cadre reports material events such as quarterly financial results, investor presentations and significant transactions. For example, the company has filed 8‑Ks to furnish earnings press releases and slide presentations, and to disclose a securities purchase agreement to acquire TYR Tactical, a manufacturer of tactical gear and equipment for military, law enforcement and government agencies worldwide. These filings also confirm details such as Cadre’s incorporation in Delaware and its CDRE listing on the New York Stock Exchange.
Through its SEC reports, Cadre discusses non‑GAAP financial measures including EBITDA, adjusted EBITDA and adjusted EBITDA margin, explaining how these metrics relate to its GAAP results. Filings may also describe contract awards, like blast exposure monitoring programs handled by its Med‑Eng subsidiary, and provide additional context on acquisitions in nuclear safety and tactical equipment.
On Stock Titan, investors can review Cadre’s SEC filings alongside AI‑powered summaries that clarify key points in lengthy documents. Real‑time updates from EDGAR help users track new 8‑Ks, 10‑Qs and 10‑Ks as they are filed, while insider and governance‑related disclosures can be used to analyze management decisions and capital allocation. This page is a resource for understanding how Cadre communicates its financial performance, strategic transactions and risk factors through its regulatory filings.
FMR LLCDecember 31, 2025, FMR reports beneficial ownership of 3,798,654.83 shares, representing 9.3% of the outstanding common stock.
FMR, a Delaware entity, has sole voting power over 3,797,171 shares and sole dispositive power over 3,798,654.83 shares. Abigail P. Johnson, a U.S. person, is also a reporting person with sole dispositive power over 3,798,654.83 shares and no voting power. The securities are certified as being held in the ordinary course of business and not for the purpose of changing or influencing control of Cadre Holdings.
Cadre Holdings, Inc. filed an amended report to update terms of its previously disclosed acquisition of certain "Purchased Companies" by subsidiary Safariland, LLC from RG Beck AZ, Inc. The amended Securities Purchase Agreement sets an aggregate purchase price of $145,000,000, including $120,000,000 in cash, subject to customary working capital adjustments, and $25,000,000 in Cadre common stock.
The equity portion comprises $24,000,000 in unregistered Cadre shares to the seller and $1,000,000 in restricted stock units for specified employees under the 2021 Stock Incentive Plan. The transaction closed on January 30, 2026, and Cadre agreed to file a Form S-3 within 60 days of closing to register the seller’s unregistered shares for public resale. Separately, immediately after closing, the buyer or a designee will acquire related Peoria, Arizona real estate for an additional $30,000,000 in cash.
Cadre Holdings, Inc. insider Warren B. Kanders, who serves as CEO, Chairman, director and a 10% owner, reported a charitable stock gift. On 12/24/2025, he transferred 12,250 shares of Cadre common stock as a gift at a reported price of $0, moving the shares from his indirect holdings through Kanders SAF, LLC to a qualified charitable organization.
After this transaction, Kanders reported indirect beneficial ownership of 10,117,039 shares through Kanders SAF, LLC, as well as additional indirect holdings of 1,305,650 shares through a Warren B. Kanders Roth IRA and 23,450 shares through an Allison Kanders Roth IRA. He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Cadre Holdings' chief financial officer Blaine Browers reported selling 20,435 shares of common stock on 12/12/2025 at a weighted average price of $43.79 per share. After this transaction, he directly beneficially owned 63,142 shares of Cadre Holdings common stock.
The sale was reported as a single transaction in the filing, with shares sold in multiple trades at prices ranging from $43.41 to $44.31 per share.
An affiliate of CDRE has filed a Form 144 notice to sell up to 20,435 shares of common stock through UBS Financial Services Inc.. The planned sale, listed for execution on or about 12/12/2025 on the NYSE, has an indicated aggregate market value of $899,140. The shares were originally acquired as restricted stock units (RSUs) from the issuer on 03/18/2022. The filing also notes that there were 40,663,844 shares of this class outstanding at the time referenced, providing context for the size of the proposed transaction.
Cadre Holdings, Inc. president Brad Williams reported a sale of company stock. On 12/10/2025, he sold 24,000 shares of Cadre Holdings common stock in an open-market transaction. The weighted average sale price was $42.99 per share, with individual trades executed between $41.84 and $43.39 per share. After this transaction, Williams beneficially owns 54,719 shares of Cadre Holdings common stock, held directly.
Cadre Holdings insider files to sell additional shares under Rule 144. A holder plans to sell 24,000 shares of Cadre Holdings common stock through UBS Financial Services on the NYSE, with an aggregate market value of approximately $1,031,309.14. These shares were acquired as restricted stock units from the issuer on March 18, 2024.
As context, 40,663,844 shares of Cadre Holdings common stock were outstanding at the time of this notice. Over the past three months, the same seller completed multiple open-market sales, including a 27,370‑share transaction on November 13, 2025 that generated gross proceeds of $1,193,840. The seller represents that they are not aware of any undisclosed material adverse information about the company’s current or prospective operations.
Cadre Holdings (CDRE)Warren B. Kanders, reflecting recent trades and his current stake. He now beneficially owns 11,692,570 shares of common stock, representing about 27.7% of the company. This total includes shares held directly, in his Roth IRA, through Kanders SAF, LLC, options to purchase 232,635 shares that are exercisable within 60 days, and 23,450 shares held in his wife’s Roth IRA. It excludes additional stock options and restricted stock units that are not yet exercisable or vested.
The ownership percentage is calculated using 42,245,528 shares deemed outstanding, including certain vested awards and in-the-money options. On November 17, 2025, Kanders sold 1,257,038 shares and Kanders SAF sold 86,903 shares of Cadre Holdings common stock in a Rule 144 block trade at $39.00 per share. Of the shares beneficially owned, a total of 3,750,000 shares have been pledged as collateral in favor of Texas Capital Bank under an existing loan agreement.
Cadre Holdings, Inc. (CDRE) CEO and Chairman Warren B. Kanders reported significant stock sales. On 11/17/2025, he sold 1,257,038 shares of Cadre common stock at $39 per share in a direct transaction, leaving him with 1,546 directly held shares. He also reported an indirect sale of 86,903 shares at $39 per share through Kanders SAF, LLC, after which that entity held 10,129,289 shares indirectly for him.
In addition, Kanders reported indirect beneficial ownership of 1,305,650 shares held in the Warren B. Kanders Roth IRA and 23,450 shares held in the Allison Kanders Roth IRA. He is listed as a director, 10% owner, and CEO and Chairman, and disclaims beneficial ownership of certain indirect holdings except to the extent of his pecuniary interest.
Cadre Holdings (CDRE) filed a Form 144 notice for the proposed sale of 1,343,941 common shares through broker Merrill Lynch on the NYSE, with an approximate sale date of 11/17/2025.
The shares listed have an aggregate market value of $56,566,477 based on the filing data. The filing reports that 40,663,844 shares of the issuer’s common stock are outstanding, providing context for the size of the potential sale.
The securities to be sold include shares acquired on 12/07/2021 via a liquidating distribution and shares acquired on 11/10/2025 upon the vesting and settlement of restricted stock units under the issuer’s 2021 Stock Incentive Plan.
FAQ
What is the current stock price of Cadre Hldgs (CDRE)?
What is the market cap of Cadre Hldgs (CDRE)?
